Announcing new research consortium + partnership with Celgene
View this email in your browser
This Fall B-term, Columbia will be offering another session of the six-week course called Intellectual Property for Entrepreneurs, which Jeff Sears (Columbia’s Chief Patent Counsel) and I will be teaching. The course is open to all current Columbia students, faculty, and staff. Last year, we had great speakers from Fortune 500 (Google, IBM, Nokia, Yahoo), venture capital (NEA, Matrix Partners, Foundation Medical Partners, Osage), the patent world (USPTO, premier patent prosecutors and litigators), patent assertion entities (Acacia), entrepreneurs (Infinio, Phosplatin Therapeutics), and emerging models for patent monetization (Patent Properties, Drug Royalty International). We also run a simulated IP license negotiation exercise which has been a lot of fun. Registration is open - the syllabus can be found here; register via SSOL or Courseworks (Course IEORE4577), or if that fails you, via the request form here. If you aren't on campus, we'll also share videos from the class on our website in early 2017 (some videos from the fall 2015 course are also available here).

Best wishes with your summer projects, and we look forward to seeing you in the fall! Don't forget to register for our events and lectures, as well as check out some exciting news, below. 


Orin Herskowitz
Executive Director, CTV
VP for Intellectual Property & Technology Transfer
Columbia University was ranked number 9 out of 100 universities granted U.S. patents by the National Academy of Inventors, with 119 utility patents issued in 2015.

Columbia, U Penn, Johns Hopkins, and Mount Sinai received $50M from Celgene to launch a collaborative research consortium aiming to change the course of cancer care.

PureTech Health announced the launch of Vor BioPharma, aiming to discover a new class of targeted cell therapies from the lab of Columbia’s Siddhartha Mukherjee.

Columbia startup (and NYC-based) Lumiode closed on a significant round of financing from the IP Group to further advance the next generation of microdisplay technologies for portable, head-worn, high brightness, energy efficient, transparent, daylight-readable displays.

Sapience Therapeutics, a Columbia startup using novel compounds from Dr. Lloyd Greene’s lab to target brain cancer, raised over $22M from a number of top-tier investors.

VidRovr, a startup commercializing video recognition and analytics technology out of the lab of Dr. Shih-Fu Chang and a top graduate of the NYC Media Lab’s Combine program, won a spot (one of the top 12 teams out of 3500+ world applicants) to receive funding from Publicis Groupe in their Publicis 90 Startup Competition.
Thursday, 7/21, 10:30am, eBay NYC - Startup Global Seminar - Join the USPTO for an event featuring educational seminars in partnership with local incubators and accelerators to cover the most-pressing issues startups face in the global environment. Learn from a variety of speakers including panelists from eBay, Microsoft and Kickstarter.

Wednesday, 7/27, 6pm, Coolly LLC - Transitioning to CEO: How Start-ups by Women in Life Sciences Succeed - Join Columbia Business School Alumni Club of NY and Columbia WIN for a discussion with top women academics in the life sciences who have made the transition to entrepreneur. 

Tuesday, 9/13 (CUMC) + Wednesday, 9/14 (Morningside), 4pm - ELabNYC Info Sessions - Calling all bioentrepreneurs! Thinking of starting your own bio or health tech company? Entrepreneurship Lab NYC  is looking for interested research scientists, doctors and engineers for upcoming 2017 cohort. Learn more at one of the upcoming info sessions. 
Friday,  9/16, 12pm, Morningside - Financing Your Startup: All Money is Not Equal - Securing financing is a challenge for any startup, but understanding the path to financing and common pitfalls you may encounter along the way will pay off in the long term. This info session will cover different financing models for startups, what to expect in negotiations, and more.
Thursday, 9/22, 8am, Morningside - NYC Media Lab 2016 Annual Summit - The fourth annual NYC Media Lab Summit is a snapshot of the best thinking, projects, and talent in digital media from universities in NYC and beyond. This is an opportunity for media execs, technologists, and decision makers to explore the future of media.

Friday, 10/21, 11am, Morningside - Patents 101 - As the Columbia technology transfer experience demonstrates, patents can provide a successful vehicle for generating research funding for university inventions. This session offers a patent law primer focusing on what you need to know to preserve patent protection for your inventions.
Wednesday, 11/9, CUMC - Venture Capital Investing in the Biotech Startup Space - Join Columbia WIN for a discussion exploring venture capital investing in biotech companies with Charlotte Hubbert of The Bill & Melinda Gates Foundation.
Friday, 11/18, CUMC - Fireside Chat with Nina Tandon and Hemai Parthasarathy - Join Columbia WIN for a discussion between two leading members of the early-stage biotech community. Nina Tandon, CEO and co-founder of EpiBone, and Hemai Parthasarathy, Scientific Director of Breakout Labs and the Thiel Foundation will discuss lessons on entrepreneurship, advice for those looking to launch their own companies., and more.
Apply to the Tamer Fund for Social Ventures - Deadline Monday, 8/15 - Applications are now open for the Tamer Fund for Social Ventures. This Fund provides seed grants of up to $25,000 to nonprofit, for-profit, and hybrid early-stage social ventures.

Call for Proposals: Allied-Bristol Life Sciences - Deadline Thursday, 9/1 - Apply for the CATALYST program, which aims to identify and develop commercially-promising biopharmaceutical innovations from leading universities and research institutions.
Biomimetic passive cooling and heating system | Learn more

Murine model for anorexia nervosa | Learn more

Gelatin-bound avidin for targeted radiotherapy for cancer | Learn more

Identification of Earth-based targets for efficient photography from outer space | Learn more

TPH1 inhibition for a non-cytotoxic leukemia treatment | Learn more

Columbia University has over 1200 active patent assets available for licensing. Click here to discover more
Have something you'd like to see included? Email
Copyright © 2016 Columbia Technology Ventures, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list